The positivity of the antibody anti-SS-A/Ro is associated with clinical SLE manifestations, such as leukopenia, subacute cutaneous lupus, neonatal lupus, and congenital heart block [21,22,23]. Here, CALR is linked to systemic lupus erythematosus.